<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
	<channel>
		<title>Publications by D. Kanjanapothi</title>
		<link>http://cfs.nrcan.gc.ca/authors/read/18687?lang=en_CA</link>
		<description>Publications by D. Kanjanapothi</description>
		<language>en-ca</language>
		<pubDate>2003-06-16 00:00:00 MST</pubDate>
		<lastBuildDate>2003-06-16 00:00:00 MST</lastBuildDate>
		<webMaster>webmaster@nofc.cfs.nrcan.gc.ca</webMaster>
		        		<item>
			<title>Pharmocokinetics, metabolism and toxicity of the plant-derived photoxin-terthienyl</title>
			<link>http://cfs.nrcan.gc.ca/publications?id=21947</link>
			<description>The plant-derived insecticide. a-terthienyl was prepared by synthesis as 3' ,4' -di[4C]-a-terthienyl for pharmacokinetic
and metabolism studies. When administered orally to rats at a single dose of 50 mg/kg, excretion of the labelled material was maximal one day after administration and declined to no measurable quantities by day 4. Tho metabolites [1.4-di(2'·thienyl)I ,4-butadione and 2-2'-bithiophene-5-&amp;lt;:arboxylic acid] and trace quantities of the parent material were
isolated from the urine and chemically identified. These represent the first metabolites of a.tenhienyl identified. In pilot acute and subacute trials, unlabelled a-terthienyl was non-toxic when administered orally to rats as the &quot;ready to use&quot;
formulation (0.1% active ingredient). The pure compound had an LO&quot;, of 110 mgikg when administered intraperitoneally
to rats. The results suggest that there is considerable separation with respect to mosquito larvae and non-target mammal sensitivity.</description>
			<pubDate>Mon, 16 Jun 2003</pubDate>
			<guid>http://cfs.nrcan.gc.ca/publications?id=21947</guid>
		</item>
		
	</channel>
</rss>